1/12
insulin
injectable hypoglycemic that promotes the cellular uptake of glucose, its conversion into glycogen, and its storage in the liver and muscles. also promotes the conversion of amino acids into proteins, the uptake of potassium into cells, and the conversion of fatty acids into triglycerides. treats T1DM and T2DM that cannot be controlled by diet or oral hypoglycemics as well as gestational diabetes. ADRs include hypoglycemia, hypokalemia, lipodystrophy via continuous injections at the same site, and allergic reactions. monitor client for s/s of hypoglycemia closely, along with monitoring potassium levels and EKGs. adjust dosing in response to caloric needs/carb intake, infections, stress, wt gain, and pregnancy. a high alert medication that requires verification from another nurse before administering. vials can be stored at room temp for 28 days; pre-filled syringes can be stored in the fridge for 1-2 weeks.
lispro/aspart
a rapid acting insulin with an onset of 15 to 30 mins. eat a meal within 15 minutes of taking this form of insulin.
regular
a short acting insulin with an onset of 30 min to 1 hour. eat a meal within 30 mins of take this form of insulin.
NPH/determir
an intermediate acting insulin with an onset of 1 to 2 hours. eat a meal 4 hours after taking this form of insulin in the morning. patient may need a snack before bed if blood glucose is low come bedtime.
glargine (Lantus)
a long-acting insulin with an onset of 70 min. patient should take this form of insulin even if they do not eat.
rapid-acting peak
30 min to 2.5 hours
short-acting peak
1 to 5 hours
intermediate-acting peak
6 to 14 hours
long-acting peak
none-levels are steady
rapid-acting duration
3 to 6 hours
short-acting duration
6 to 10 hours
intermediate-acting duration
16 to 24 hours
long-acting duration
18 to 24 hours